Tumor-infiltrating effector cells of α-galactosylceramide-induced antitumor immunity in metastatic liver tumor
Journal of Immune Based Therapies and Vaccines · 2004
DOI: 10.1186/1476-8518-2-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immune Based Therapies and Vaccines, 2004. Verfasst von Takuya Osada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. takuosa1962@hot…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: alpha-Galactosylceramide (alpha-GalCer) can be presented by CD1d molecules of antigen-presenting cells, and is known to induce a potent NKT cell-dependent cytotoxic response against tumor cells. However, the main effector cells in alpha-GalCer-induced antitumor immunity are still controversial. METHODS: In order to elucidate the cell phenotype that plays the most important role in alpha-GalCer-induced antitumor immunity, we purified and analyzed tumor-infiltrating leukocytes (TILs) from liver metastatic nodules of a colon cancer cell line (Colon26), comparing alpha-GalCer- and control vehicle-treated mice. Flow cytometry was performed to analyze cell phenotype in TILs and IFN-gamma ELISA was performed to detect antigen-specific immune response. RESULTS: Flow cytometry analysis showed a significantly higher infiltration of NK cells (DX5+, T cell receptor alphabeta (TCR)-) into tumors in alpha-GalCer-treated mice compared to vehicle-treated mice. The DX5+TCR+ cell population was not significantly different between these two groups, indicating that these cells were not the main effector cells. Interestingly, the CD8+ T cell population was increased in TILs of alpha-GalCer-treated mice, and the activation level of these cells based on CD69 expression was higher than that in vehicle-treated mice. Moreover, the number of tumor-infiltrating dendritic cells (DCs) was increased in alpha-GalCer-treated mice. IFN-gamma ELISA showed stronger antigen-specific response in TILs from alpha-GalCer-treated mice compared to those from vehicle-treated mice, although the difference between these two groups was not significant. CONCLUSIONS: In alpha-GalCer-induced antitumor immunity, NK cells seem to be some of the main effector cells and both CD8+ T cells and DCs, which are related to acquired immunity, might also play important roles in this antitumor immune response. These results suggest that alpha-GalCer has a multifunctional role in modulation of the immune response.
Autor:innen und Institutionen
- Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. takuosa1962@hotmail.com
Zitieren
APA
Osada, T., Nagawa, H., & Shibata, Y. (2004). Tumor-infiltrating effector cells of α-galactosylceramide-induced antitumor immunity in metastatic liver tumor. Journal of Immune Based Therapies and Vaccines. https://doi.org/10.1186/1476-8518-2-7
Vancouver
Osada T, Nagawa H, Shibata Y. Tumor-infiltrating effector cells of α-galactosylceramide-induced antitumor immunity in metastatic liver tumor. Journal of Immune Based Therapies and Vaccines. 2004. doi:10.1186/1476-8518-2-7
BibTeX
@article{Osada2004,
author = {Osada, Takuya and Nagawa, Hirokazu and Shibata, Yoichi},
title = {Tumor-infiltrating effector cells of α-galactosylceramide-induced antitumor immunity in metastatic liver tumor},
journal = {Journal of Immune Based Therapies and Vaccines},
year = {2004},
doi = {10.1186/1476-8518-2-7}
}
EUVIMED